CIK 0001762303 · Non-accelerated filer<br>Smaller reporting company
AVITA Medical, Inc.
Sign in to watch- Tickers
- RCEL AVHHL
- Exchange
- Nasdaq, OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202578762
- Phone
- 661-568-1317
- Business address
- 28159 AVENUE STANFORD, SUITE 220, VALENCIA, CA, 91355
- Former names
- Avita Therapeutics, Inc., Avita Medical, Ltd.
Securities
- RCEL Common Stock Nasdaq
- AVHHL Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-21 | PERRY MICHAEL S Director | Sale | −150,000 | $7.18 | $1.1M | 229,543 |
| 2022-11-21 | PERRY MICHAEL S Director | Option exercise · Stock Options (Right to Buy) | −150,000 | 0 | ||
| 2022-09-01 | PERRY MICHAEL S Chief Executive Officer | Grant or award | +2,980 | 300,983 | ||
| 2022-09-01 | PERRY MICHAEL S Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +3,450 | 6,900 | ||
| 2022-07-01 | Holder Michael Chief Financial Officer | Grant or award | +35,950 | 46,450 | ||
| 2022-07-01 | Holder Michael Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +20,650 | 20,650 | ||
| 2022-07-01 | Liberto Erin Chief Commercial Officer | Grant or award | +35,950 | 46,450 | ||
| 2022-07-01 | Liberto Erin Chief Commercial Officer | Grant or award · Stock Options (Right to Buy) | +20,650 | 20,650 | ||
| 2022-07-01 | McGee Kathy M. Chief Operating Officer | Grant or award | +35,950 | 46,450 | ||
| 2022-07-01 | McGee Kathy M. Chief Operating Officer | Grant or award · Stock Options (Right to Buy) | +20,650 | 20,650 | ||
| 2022-07-01 | Quick Andrew Chief Technology Officer | Grant or award | +35,950 | 46,450 | ||
| 2022-07-01 | Quick Andrew Chief Technology Officer | Grant or award · Stock Options (Right to Buy) | +20,650 | 20,650 | ||
| 2022-07-01 | Shiroma Donna General Counsel | Grant or award | +35,950 | 46,450 | ||
| 2022-07-01 | Shiroma Donna General Counsel | Grant or award · Stock Options (Right to Buy) | +20,650 | 20,650 | ||
| 2022-06-01 | PERRY MICHAEL S Chief Executive Officer | Other disposition | −23,754 | 297,958 | ||
| 2022-02-24 | PERRY MICHAEL S Chief Executive Officer | Sale | −10,812 | $8.74 | $94K | 321,712 |
| 2022-02-23 | PERRY MICHAEL S Chief Executive Officer | Grant or award | +23,753 | 326,564 | ||
| 2022-02-23 | PERRY MICHAEL S Chief Executive Officer | Grant or award | +5,960 | 332,524 | ||
| 2022-02-23 | PERRY MICHAEL S Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +3,450 | 3,450 | ||
| 2021-12-22 | Panaccio Lou Director | Grant or award | +4,350 | 18,442 |
Page 8 of 10 · 185 trades